Authors of meta-analysis on heart disease retract it when they realize a NEJM reference had been retracted

Carl Heneghan

The authors of a meta-analysis on predicting cardiovascular disease have retracted the paper because it included a study that was retracted between the time they submitted their article and the date it was published. 

If only there were a repository of retracted articles that authors and editors could check to see if the references in the studies they publish are still reliable.

Wait, we have one of those!

Continue reading Authors of meta-analysis on heart disease retract it when they realize a NEJM reference had been retracted

Researcher, until last week a Miami dean, faked data in grant applications, says federal watchdog

Charles A. Downs, via University of Miami

A former researcher at the University of Arizona who is now was until last week an associate dean at the University of Miami “engaged in research misconduct by intentionally, knowingly, or recklessly falsifying and/or fabricating data” in six federal grant applications, according to a new finding by the U.S. Office of Research Integrity (ORI).

Charles A. Downs’ work “focuses on acute lung injury and pulmonary diseases,” according to a 2018 press release from the University of Miami announcing his appointment. He “neither admits nor denies ORI’s findings of research misconduct,” the ORI announced today. The agency said that Downs

Continue reading Researcher, until last week a Miami dean, faked data in grant applications, says federal watchdog

Researcher at Tehran medical school loses three papers because “overlap without cross-referencing is not legitimated”

Hamid Akbari Javar

A pharmacy researcher at Tehran University of Medical Sciences has had three papers retracted, and one corrected, because he duplicated his other articles.

Hamid Akbari Javar is the common author on all four papers, which appear in the African Journal of Pharmacy and Pharmacology, the International Journal of Pharmaceutical Sciences and Research, the Indian Journal of Pharmaceutical Sciences, and the International Journal of Molecular Medicine

Narges Shokri, of the School of Pharmacy of Ardabil University of Medical Sciences, also in Iran, is an author of the three retracted papers, but not the corrected paper in the International Journal of Molecular Medicine.

Here’s the notice for “Comparison of Calcium Phosphate and Zinc Oxide Nanoparticles as Dermal Penetration Enhancers for Albumin,” in the Indian Journal of Pharmaceutical Sciences:

Continue reading Researcher at Tehran medical school loses three papers because “overlap without cross-referencing is not legitimated”

Public health journal “seeking further expert advice” on January paper about COVID-19 PCR testing by high-profile virologist

After a petition from nearly two dozen people in Europe, the United States and Asia, a public health journal says it is investigating an article it published last January about a way to detect the virus that causes COVID-19. 

[Please see an update on this post.]

The paper, “Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR,” appeared in Eurosurveillance. It was received on January 21 and accepted on January 22, a remarkably quick turnaround under normal circumstances, although not unheard of during the pandemic. It has been cited well over 800 times, according to Clarivate Analytics’ Web of Science.

The senior author of the work was Christian Drosten, of the Charité University Hospital in Berlin, who became something of a celebrity virologist — the Anthony Fauci of Germany — in the early days of the pandemic. As Science reported in late April, Drosten’s podcast, Coronavirus Update, became the most popular podcast in Germany, garnering more than 1 million downloads per episode.

Continue reading Public health journal “seeking further expert advice” on January paper about COVID-19 PCR testing by high-profile virologist

Western University materials scientist committed misconduct, according to investigation

Bernd Grohe

An investigation into the work of a researcher at Western University “resulted in a clear determination of research misconduct,” according to a retraction notice, but details are scant.

Here’s the notice for “Synthetic peptides derived from salivary proteins and the control of surface charge densities of dental surfaces improve the inhibition of dental calculus formation,” published in Materials Science and Engineering: C in 2017 by Bernd Grohe:

Continue reading Western University materials scientist committed misconduct, according to investigation

Weekend reads: Google AI researcher fired after being asked to retract paper; journal accused of stonewalling on paper “used to justify human rights violations;” reflecting on a COVID-19 retraction

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured:

Our list of retracted or withdrawn COVID-19 papers is up to 39.

Here’s what was happening elsewhere:

Continue reading Weekend reads: Google AI researcher fired after being asked to retract paper; journal accused of stonewalling on paper “used to justify human rights violations;” reflecting on a COVID-19 retraction

Bad, Medicine: Journal publishes doubly-brutal retraction notice

A journal has retracted a paper it published earlier this year for pretty much every sin under the sun, scoring an own-goal in the process. 

The article, “Effects and safety of tanreqing injection on viral pneumonia: A protocol for systematic review and meta-analysis,” was led by Yue Qiu, of the Beijing University of Chinese Medicine and appeared in Medicine on September 11.

The tl;dr version of this post: We have questions.

Continue reading Bad, Medicine: Journal publishes doubly-brutal retraction notice

COVID-19 pneumonia paper earns expression of concern — for being similar to a pre-pandemic article

Researchers in China have received an expression of concern for a recent paper on COVID-19 pneumonia after editors were alerted to suspicious similarities between the tables in the article and those in a 2018 study by members of the same group.

In case you missed that: The pandemic started long after 2018.

Continue reading COVID-19 pneumonia paper earns expression of concern — for being similar to a pre-pandemic article

Journal retracts 70-year-old article on homosexuality for “long discredited beliefs, prejudices, and practices”

We wrote in September in WIRED about a trend among journals of purging racist and sexist work from their archives. To that trend we can now add papers that are homophobic and racist.

The Journal of Nervous and Mental Disease has retracted a 1951 article by one Benjamin H. Glover, at the time a professor of psychology at the University of Wisconsin–Madison. The article, “Observations on Homosexuality Among University Students,” claimed that:

Continue reading Journal retracts 70-year-old article on homosexuality for “long discredited beliefs, prejudices, and practices”

A year after a federal misconduct finding, a cancer researcher loses a paper

Sudhakar Yakkanti

A cancer specialist formerly affiliated with Boys Town National Research Hospital in Nebraska who was found to have committed misconduct in nearly 20 grant applications and papers has lost an article in Scientific Reports — a year after his misconduct case became public. 

According to the journal, which, to its credit, flagged the paper with an editor’s note last February, the delay stemmed from efforts to verify information that was not part of the official inquiry. 

The article, “Type IV collagen α1-chain noncollagenous domain blocks MMP-2 activation both in-vitro and in-vivo,” was written by a group led by Yakkanti Akul Sudhakar, whose name — last, at least — might be familiar to RW readers. 

In November 2019, Sudhakar — who also has published as Sudhakar Yakkanti and Akulapalli Sudhakar — was sanctioned by the U.S. Office of Research Integrity for: 

Continue reading A year after a federal misconduct finding, a cancer researcher loses a paper